US2528281080
US2528281080
Dianthus Therapeutics, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 2.036.000 | 6.235.000 | 67.3% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| 179.969.000 | 108.099.000 | 66.5% | |
| Operating Income | -177.933.000 | -101.864.000 | 74.7% |
| Pretax Income | -162.337.000 | -84.969.000 | 91.1% |
| Net Income Common Stockholders | -162.337.000 | -84.969.000 | 91.1% |
| -- | -- | -- | |
| -- | -- | -- |